The dilemma of neoadjuvant and adjuvant therapy in urothelial carcinoma: will immunotherapy solve the problem?

Immunotherapy. 2022 Mar;14(4):171-174. doi: 10.2217/imt-2021-0324. Epub 2022 Jan 10.

Authors

Giacomo Nuvola¹, Alessandro Rizzo¹, Veronica Mollica¹, Francesco Massari¹

Affiliation

¹ Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Via Albertoni - 15, Bologna, Italia.

PMID: 35000464
DOI: 10.2217/imt-2021-0324

No abstract available

Keywords: adjuvant; bladder cancer; immunotherapy; neoadjuvant; urothelial carcinoma.

Publication types

Review

MeSH terms

Chemotherapy, Adjuvant / methods*
Humans
Immunotherapy / methods*
Neoadjuvant Therapy / methods*
Urologic Neoplasms / drug therapy*
Urologic Neoplasms / immunology*